These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Health effects: pregnancy use of diethylstilbestrol.
    Author: Dugan WM.
    Journal: J Indiana State Med Assoc; 1979 May; 72(5):332-4. PubMed ID: 458172.
    Abstract:
    The use of DES (diethylstilbestrol) to prevent pregnancy complications and miscarriages has shown effects in women who took DES and their offspring. A University of Chicago follow-up study indicated that women who had used DES had more breast and gynecological cancers than a control group, although the results were statistically insignificant. DES daughters have a higher occurrence of a rare malignant vaginal cancer, clear cell adenocarcinoma, and DES-exposed males showed a history of cryptorchidism, hypoplastic testes, epididymal cysts, and low sperm counts. A DES Task Force formed by the Office of the Assistant Secretary for Health in 1978 recommends that all persons exposed to DES be informed of health risks and that DES daughters be carefully monitored by using Pap smears, iodine staining, and colposcopy when necessary. In addition, the Task Force recommends that DES women not use estrogens, that postmenopausal replacement estrogens be prescribed prudently, that DES not be given to suppress lactation, and that women given DES for postcoital contraception be informed of the possible health risks.
    [Abstract] [Full Text] [Related] [New Search]